Aurora kinase inhibitors have been examined as anti-MM agents in other studies and a few such inhibitors inhibited other receptor tyrosine kinases (RTKs) in addition to aurora kinases [17, 20]. The gene discussed is NTRK1; the disease is Miyoshi myopathy.